Prostate cancer expert, Dr. David Samadi, shares news about the identification of a single lung cancer gene, MMP10, which could be targeted to control the growth and spread of lung cancer cells. Lung cancer is the leading cause of cancer deaths in the U.S. and is responsible for more deaths that prostate cancer, breast cancer, and colon cancer combined. This new form of lung cancer treatment could be used to attack the cancer stem cells that are often resistant to radiation or chemotherapy. As such, Dr. Samadi explains that identifying this gene is a step toward breaking the genetic code of cancer and could help significantly reduce the rate of cancer recurrence. This breakthrough could prove meaningful for the future treatment of prostate cancer, melanoma, and other cancers in the future. http://www.roboticoncology.com
